Costly Cures.
Effective but very expensive drugs are forcing state Medicaid directors to make some tough decisions.
Michael
M
Booth
D002017:Budgets; D006526:Hepatitis C / Q000188:drug therapy* / Q000191:economics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D008484:Medicaid / Q000191:economics*; D012720:Severity of Illness Index; D000069474:Sofosbuvir / Q000191:economics* / Q000627:therapeutic use; D013219:State Government; D014481:United States
D000069474:Sofosbuvir